Local
Understanding Kentucky’s blood shortage
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: The Kentucky Kernel

For Dr. Zena Chadhine, a shortage of blood can stand between her patients and the treatment they need. As a hematologist-oncologist at University of Kentucky HealthCare, Chadhine said she works with people during some of the most vulnerable periods of their lives as they navigate blood cancer. Many patients undergo chemotherapy to fight the illness, but this treatment can also damage healthy blood cells, resulting in dangerously low red blood cell and platelet counts, according to Chadhine. For patients undergoing more intensive treatments, such as stem cell transplants, chemotherapy effects can be even more severe. Chadhine said the treatment destroys the patient’s bone marrow, temporarily preventing the body from producing its own red blood cells and platelets. Until their bone marrow recovers, these patients become dependent on transfusions to replace the blood cells their bodies can no longer produce. Some of her patients will rely on one or more transfusions a day.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at The Kentucky Kernel


